• Careers
  • Investors
  • News
  • Partnering
  • Contact Us
 
  • Home
  • Our Products
    • Recent Products
    • Consumer Products
    • Medical Devices & Diagnostics
    • Prescription Products
    • Product Coupons
  • Our Caring
    • Our Stories
    • Our Giving
    • Our Responsibility
    • Protecting Our People
    • Company Initiatives
  • Our Company
    • Our Credo Values
    • Our Management Approach
    • Our Citizenship
    • Corporate Governance
    • Company Structure
    • Our People & Diversity
    • Company Publications
    • Our History
  • News
    • All News
    • Corporate News
    • Product And Operating Company News
    • Financial News
    • Media Contacts
    • All News Archive
  • Text Size
  • Text Only
  • Email to a Friend
  • Printer Friendly
  • RSS

All News

Find press releases issued in the past two years issued by Johnson & Johnson corporate headquarters and our operating companies.

< Prev | | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39....
Tibotec To Present Final Safety And Efficacy Results From Phase 2b PILLAR Study Of Once-Daily TMC435 In Late-Breaker At AASLD

November 05, 2011

SterilMed Names Mike Gustafson Company President

November 04, 2011

Ethicon-Endo Surgery Completes Acquisition of SterilMed

November 04, 2011

FDA Approves XARELTO® (Rivaroxaban) To Reduce The Risk Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation

November 04, 2011

Steering Drivers In The Right Direction, “Healthy Vision™ With Dr. Val Jones” Radio Show Offers Information, Advice About Driving In The Dark

November 01, 2011

Supplemental New Drug Application Submitted To FDA For NUCYNTA® ER (Tapentadol) Extended-Release Tablets For Diabetic Peripheral Neuropathic Pain

October 31, 2011

< Prev | | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39....
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Employees
  • Careers
  • Investors
  • News
  • Partnering
  • Contact Us
Johnson & Johnson
  • Home
  • Our Products
  • Our Caring
  • Our Company
  • All News
  • Corporate News
  • Product And Operating Company News
  • Financial News
  • Media Contacts
  • All News Archive
  • Text Size
  • Graphic Version
  • Email to a Friend
  • Printer Friendly
  • RSS

All News

Find press releases issued in the past two years issued by Johnson & Johnson corporate headquarters and our operating companies.

< Prev | | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39....
Tibotec To Present Final Safety And Efficacy Results From Phase 2b PILLAR Study Of Once-Daily TMC435 In Late-Breaker At AASLD

November 05, 2011

SterilMed Names Mike Gustafson Company President

November 04, 2011

Ethicon-Endo Surgery Completes Acquisition of SterilMed

November 04, 2011

FDA Approves XARELTO® (Rivaroxaban) To Reduce The Risk Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation

November 04, 2011

Steering Drivers In The Right Direction, “Healthy Vision™ With Dr. Val Jones” Radio Show Offers Information, Advice About Driving In The Dark

November 01, 2011

Supplemental New Drug Application Submitted To FDA For NUCYNTA® ER (Tapentadol) Extended-Release Tablets For Diabetic Peripheral Neuropathic Pain

October 31, 2011

< Prev | | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39....
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •